Appropriateness of therapy for fistulizing Crohn's disease: Findings from a national inflammatory bowel disease cohort

Alimentary Pharmacology and Therapeutics

Volumn 32, Issue 8, 2010, Pages 1007-1016

  Pittet, V ^a   Juillerat, P ^a,b   Michetti, P ^b   Vader, J P ^a   Burnand, B ^a   Rogler, G ^c   Beglinger, C ^d   Seibold, F ^e   Mottet, C ^f   Felley, C ^b   Gonvers, J J ^b   Froehlich, F ^b,d  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e UNIVERSITY OF BERN   (Switzerland)

^f Division of Gastroenterology Hôpital Neuchâtelois   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTIBIOTIC AGENT; AZATHIOPRINE; CERTOLIZUMAB PEGOL; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; STEROID; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ARTICLE; CLINICAL EVALUATION; COHORT ANALYSIS; COLON SURGERY; CROHN DISEASE; DIGESTIVE SYSTEM FISTULA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUESTIONNAIRE; TREATMENT INDICATION;

ADULT; ANTIBODIES, MONOCLONAL; COHORT STUDIES; CROHN DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; FISTULA; GASTROINTESTINAL AGENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; QUALITY ASSURANCE, HEALTH CARE; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 77957220829     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04434.x     Document Type: Article

References (27)

1. Schwartz DA, Loftus EV Jr., Tremaine WJ, et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 2002 122: 875 880.
2. Bell SJ, Williams AB, Wiesel P, Wilkinson K, Cohen RC, Kamm MA. The clinical course of fistulating Crohn's disease. Aliment Pharmacol Ther 2003 17: 1145 1151. (Pubitemid 36605751)
3. Judge TA, Lichtenstein GR. Treatment of fistulizing Crohn's disease. Gastroenterol Clin North Am 2004 33: 421 454.
4. Michetti P. Fistula treatment: the unresolved challenge. Dig Dis 2009 27: 387 393.
5. Nielsen OH, Rogler G, Hahnloser D, Thomsen OO. Diagnosis and management of fistulizing Crohn's disease. Nat Clin Pract Gastroenterol Hepatol 2009 6: 92 106.
6. Brook RH, Chassin MR, Fink A, Solomon DH, Kosecoff J, Park RE. A method for the detailed assessment of the appropriateness of medical technologies. Int J Technol Assess Health Care 1986 2: 53 63.
7. Fitch K, Bernstein SJ, Aguilar MD, et al. The Rand/UCLA Appropriateness Method User's Manual. MR-1269-DG-XII/RE. Santa Monica: RAND Corporation, 2001. Available at: http://www.rand.org/pubs/monograph-reports/MR1269.
8. Pittet V, Juillerat P, Mottet C, et al. Cohort profile: The Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS). Int J Epidemiol 2009 38: 922 931.
9. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989 170: 2 6.
10. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005 19 (Suppl. A 5 36.
11. Sandborn WJ, Fazio VW, Feagan BG, Hanauer SB. AGA technical review on perianal Crohn's disease. Gastroenterology 2003 125: 1508 1530. (Pubitemid 37409772)
12. Juillerat P, Froehlich F, Felley C, et al. EPACT II: project and methods. Digestion 2007 76: 84 91. (Pubitemid 351194901)
13. Michetti P, Stelle M, Juillerat P, et al. Appropriateness of therapy for active Crohn's disease: results of a multidisciplinary international expert panel-EPACT II. J Crohn's & Colitis 2009 3: 232 240.
14. Felley C, Vader JP, Juillerat P, et al. Appropriate therapy for fistulizing and fibrostenotic Crohn's disease: results of a multidisciplinary expert panel - EPACT II. J Crohn's & Colitis 2009 3: 250 256.
15. Juillerat P, Vader JP, Felley C, et al. Appropriate maintenance treatment for Crohn's disease: results of a multidisciplinary international expert panel - EPACT II. J Crohn's & Colitis 2009 3: 241 249.
16. Mottet C, Vader JP, Felley C, et al. Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): results of a multidisciplinary international expert panel-EPACT II. J Crohn's & Colitis 2009 3: 257 263.
17. Dignass A, Van Assche G, Lindsay JO, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: current management. J Crohn's & Colitis 2010 4: 28 62.
18. Van Assche G, Dignass A, Reinisch W, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: special situations. J Crohn's & Colitis 2010 4: 63 101.
19. Froehlich F, Repond C, Mullhaupt B, et al. Is the diagnostic yield of upper GI endoscopy improved by the use of explicit panel-based appropriateness criteria? Gastrointest Endosc 2000 52: 333 341.
20. Guessous I, Juillerat P, Pittet V, et al. Evaluating appropriateness of treatment for Crohn's disease: feasibility of an explicit approach. Digestion 2007 75: 46 52. (Pubitemid 46712753)
21. Sands BE, Anderson FH, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 2004 350: 876 885. (Pubitemid 38252535)
22. Rutgeerts P, Vermeire S, Van AG. Biological therapies for inflammatory bowel diseases. Gastroenterology 2009 136: 1182 1197.
23. Bressler B, Sands BE. Review article: medical therapy for fistulizing Crohn's disease. Aliment Pharmacol Ther 2006 24: 1283 1293. (Pubitemid 44571559)
24. Colombel JF, Schwartz DA, Sandborn WJ, et al. Adalimumab for the treatment of fistulas in patients with Crohn's disease. Gut 2009 58: 940 948.
25. Feagan BG, Panaccione R, Sandborn WJ, et al. Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study. Gastroenterology 2008 135: 1493 1499.
26. Nielsen OH, Munck LK. Drug insight: aminosalicylates for the treatment of IBD. Nat Clin Pract Gastroenterol Hepatol 2007 4: 160 170.
27. Travis SP, Stange EF, Lemann M, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut 2006 55 (Suppl. 1 i16 35. (Pubitemid 43268291)